No insider purchase over the last 90 days. The latest, by GUS DANIEL, was filed 03 Nov 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended February 2026 · cache
25 of 261 declarations
At Ennis, Inc., sales weigh more than purchases: 42 sales worth EUR 6,461,022 (median EUR 92,666), against 14 purchases worth EUR 265,398 (median EUR 13,978), or 25% purchases among open-market trades. The largest sales are Irshad Ahmad's, EUR 592,675 on April 19, 2016 and EUR 583,499 on April 13, 2016, and Michael D. Magill's (Executive Vice President), EUR 532,589 on August 13, 2019. Walter D. Gruenes (Director) bought for EUR 85,321 on July 28, 2025, Daniel Gus (General Counsel & Secretary) for EUR 34,903 on May 8, 2023.
From October 31, 2025 to November 3, 2025, 3 insiders bought for EUR 52,386, including Boyne Wade Brewer (Chief Operating Officer) for EUR 29,580 on November 3. In all, 3 purchase filings are flagged as part of a cluster.
The 261 filings from 23 insiders were published from April 11, 2016 to October 19, 2026, with 136 grants and 44 option exercises. 2016 is the busiest year (48), ahead of 2025 (42). Ronald M. Graham (Vice President) and Irshad Ahmad file 27 each. Over the last twelve months: 20 filings, 4 purchases, no sale. The median delay is 1 day.
For 14 purchases with a stored 90-day result, the median is 12.5% and 57% are positive: stored past results, not a forecast. This US industrial company is worth USD 0.6 billion; insiders hold 3.1% of the capital.
Insider filings
Over the last 90 days, 4 filings published between 23 September and 19 October 2026: no open-market purchase or sale filed by an insider. 4 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 20 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Feb 2026 | 392.4 m USD | 42.6 m USD | 1.66 USD | 1.00 USD | 10-K |
| Feb 2025 | 394.6 m USD | 40.2 m USD | 1.54 USD | 3.50 USD | 10-K |
| Feb 2024 | 420.1 m USD | 42.6 m USD | 1.64 USD | 1.00 USD | 10-K |
| Feb 2023 | 431.8 m USD | 47.3 m USD | 1.82 USD | 1.00 USD | 10-K |
| Feb 2022 | 400.0 m USD | 29.0 m USD | 1.11 USD | 0.97 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.